Chinese laboratory takes on Molecular's cervical screen:
This article was originally published in Clinica
Executive Summary
Molecular Diagnostics has formed a three-year agreement with Waddell Developments aimed at beginning the commercialisation of Molecular's cervical screening systems in China. Waddell, of Vancouver, British Columbia, has made an initial order of over $2.7m.